Zevia’s headquarters are located at 15821 Ventura Blvd., Suite 145, Encino, California 91436.
Zevia’s independent auditor is Deloitte & Touche LLP.
Zevia completed its initial public offering in July 2021.
Zevia’s fiscal year end is December 31.
Zevia’s Class A common stock is listed on the New York Stock Exchange under the ticker symbol “ZVIA.”
At the present time, Zevia does not intend to pay a dividend.
Zevia’s transfer agent is American Stock Transfer & Trust Company, LLC (“AST”). You can contact AST in the following ways: Phone: (800) 937-5449 Email: help@astfinancial.com
Please contact Zevia’s transfer agent, AST, by phone or by email. Phone: (800) 937-5449 Email: help@astfinancial.com
Zevia does not have a direct stock purchase plan. However, you may purchase Zevia shares through your stockbroker, bank or other financial institution that offers brokerage services.
Zevia’s Class A common stock can be bought and sold through a stockbroker, bank or other financial institution that offers brokerage services.
Please send all questions or comments to ICR: Phone: (646) 277-1260 Email: reed.anderson@icrinc.com
Zevia is incorporated in Delaware. Our products are distributed across the U.S. and Canada through a diverse network of major retailers in the food, drug, mass, natural and ecommerce channels.
Zevia’s SEC filings, including our quarterly and annual reports, may be viewed and downloaded on the SEC Filings section of Zevia’s investor relations website at Investors.zevia.com. These reports are also available on the SEC’s website.
The CUSIP for our Class A common stock is 98955K 104.
You may opt into Zevia’s email distribution list by visiting the E-mail Alerts page.
All of Zevia’s SEC filings, including our annual reports, may be viewed and downloaded on the SEC Filings section of Zevia’s investor relations website. These reports are also available on the SEC’s website.